Rituximab:: An insider's historical perspective

被引：106

作者：

Grillo-López, AJ ^{[1
]}

机构：

[1] IDEC Pharmaceut Corp, Med & Regulatory Affairs Div, San Diego, CA 92121 USA

来源：

SEMINARS IN ONCOLOGY | 2000年 / 27卷 / 06期

关键词：

D O I：

10.1053/sonc.2000.20444

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：9 / 16

页数：8

共 29 条

[1] Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma [J].

Anderson, DR ;

GrilloLopez, A ;

Varns, C ;

Chambers, KS ;

Hanna, N .

BIOCHEMICAL SOCIETY TRANSACTIONS, 1997, 25 (02) :705-708

[2] B lymphocyte pathology in human colorectal cancer. Experimental and clinical therapeutic effects of partial B cell depletion [J].

Barbera-Guillem, E ;

Nelson, MB ;

Barr, B ;

Nyhus, JK ;

May, KF ;

Feng, L ;

Sampsel, JW .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 48 (10) :541-549

[3] Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma [J].

Berinstein, NL ;

Grillo-Lopez, AJ ;

White, CA ;

Bence-Bruckler, I ;

Maloney, D ;

Czuczman, M ;

Green, D ;

Rosenberg, J ;

McLaughlin, P ;

Shen, D .

ANNALS OF ONCOLOGY, 1998, 9 (09) :995-1001

[4]

BYRD JC, UNPUB RITUXIMAB ADM

[5]

Czuczman M. S., 1999, Proceedings of the American Association for Cancer Research Annual Meeting, V40, P719

[6] Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy [J].

Czuczman, MS ;

Grillo-López, AJ ;

White, CA ;

Saleh, M ;

Gordon, L ;

LoBuglio, AF ;

Jonas, C ;

Klippenstein, D ;

Dallaire, B ;

Varns, C .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :268-276

[7] Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs [J].

Demidem, A ;

Lam, T ;

Alas, S ;

Hariharan, K ;

Hanna, N ;

Bonavida, B .

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1997, 12 (03) :177-186

[8] ANTIBODIES AS CYTOTOXIC THERAPY [J].

DILLMAN, RO .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (07) :1497-1515

[9]

Flinn IW, 1999, BLOOD, V94, p638A

[10]

Grillo-Lopez A. J., 2000, Current Pharmaceutical Biotechnology, V1, P1, DOI 10.2174/1389201003379059

← 1 2 3 →